122 related articles for article (PubMed ID: 36403755)
1. MAGE-I proteins and cancer-pathways: A bidirectional relationship.
Pascucci FA; Escalada MC; Suberbordes M; Vidal C; Ladelfa MF; Monte M
Biochimie; 2023 May; 208():31-37. PubMed ID: 36403755
[TBL] [Abstract][Full Text] [Related]
2. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
[TBL] [Abstract][Full Text] [Related]
3. The melanoma antigen genes--any clues to their functions in normal tissues?
Ohman Forslund K; Nordqvist K
Exp Cell Res; 2001 May; 265(2):185-94. PubMed ID: 11302683
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of the MAGE protein family in stress response pathways.
Florke Gee RR; Chen H; Lee AK; Daly CA; Wilander BA; Fon Tacer K; Potts PR
J Biol Chem; 2020 Nov; 295(47):16121-16155. PubMed ID: 32921631
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between co-expressed MAGE-A proteins.
Laiseca JE; Ladelfa MF; Cotignola J; Peche LY; Pascucci FA; Castaño BA; Galigniana MD; Schneider C; Monte M
PLoS One; 2017; 12(5):e0178370. PubMed ID: 28542476
[TBL] [Abstract][Full Text] [Related]
6. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
Su S; Minges JT; Grossman G; Blackwelder AJ; Mohler JL; Wilson EM
J Biol Chem; 2013 Aug; 288(34):24809-24. PubMed ID: 23853093
[TBL] [Abstract][Full Text] [Related]
7. [Expression of MAGE-1 and MAGE-3 genes in gastric cancer and gastric biopsy tissues and its clinical significance].
Chen XH; Liu BY; Zhang DQ; Zhang Y; Zhang Y; Li JF; Zhu ZG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):310-3. PubMed ID: 15193225
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
9. The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells.
Tseng HY; Chen LH; Ye Y; Tay KH; Jiang CC; Guo ST; Jin L; Hersey P; Zhang XD
Carcinogenesis; 2012 Oct; 33(10):1871-81. PubMed ID: 22791814
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma.
Zerbini A; Pilli M; Soliani P; Ziegler S; Pelosi G; Orlandini A; Cavallo C; Uggeri J; Scandroglio R; Crafa P; Spagnoli GC; Ferrari C; Missale G
J Hepatol; 2004 Jan; 40(1):102-9. PubMed ID: 14672620
[TBL] [Abstract][Full Text] [Related]
11. Expression of MAGE-A11 in breast cancer tissues and its effects on the proliferation of breast cancer cells.
Xia LP; Xu M; Chen Y; Shao WW
Mol Med Rep; 2013 Jan; 7(1):254-8. PubMed ID: 23064813
[TBL] [Abstract][Full Text] [Related]
12. Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes.
Miyashiro I; Kuo C; Huynh K; Iida A; Morton D; Bilchik A; Giuliano A; Hoon DS
Clin Chem; 2001 Mar; 47(3):505-12. PubMed ID: 11238304
[TBL] [Abstract][Full Text] [Related]
13. A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein.
Zhang Y; Chaux P; Stroobant V; Eggermont AM; Corthals J; Maillère B; Thielemans K; Marchand M; Boon T; Van Der Bruggen P
J Immunol; 2003 Jul; 171(1):219-25. PubMed ID: 12817001
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-associated antigen genes - an update.
Sang M; Wang L; Ding C; Zhou X; Wang B; Wang L; Lian Y; Shan B
Cancer Lett; 2011 Mar; 302(2):85-90. PubMed ID: 21093980
[TBL] [Abstract][Full Text] [Related]
15. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.
Minges JT; Su S; Grossman G; Blackwelder AJ; Pop EA; Mohler JL; Wilson EM
J Biol Chem; 2013 Jan; 288(3):1939-52. PubMed ID: 23172223
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma.
Wu Y; Sang M; Liu F; Zhang J; Li W; Li Z; Gu L; Zheng Y; Li J; Shan B
Carcinogenesis; 2020 Jul; 41(7):894-903. PubMed ID: 32529260
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
[TBL] [Abstract][Full Text] [Related]
18. Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines.
Zhang S; Zhou X; Yu H; Yu Y
BMC Cancer; 2010 Apr; 10():163. PubMed ID: 20423514
[TBL] [Abstract][Full Text] [Related]
19. MAGE proteins regulate KRAB zinc finger transcription factors and KAP1 E3 ligase activity.
Xiao TZ; Suh Y; Longley BJ
Arch Biochem Biophys; 2014 Dec; 563():136-44. PubMed ID: 25107531
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of adenovirus-mediated calreticulin and melanoma-associated antigen 3 expression on non-small cell lung cancer cells.
Liu X; Sun N; Dong Y; Li J; Liu Y; Ren Y; Yang C; Zhang L; Zhou Y; Tong Z; Ding J; Zhao X; Liu Y; He R; Xu K; Wu Y; Huang Y; Wang H; Tao X; Liu Y
Int Immunopharmacol; 2015 Apr; 25(2):416-24. PubMed ID: 25704851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
